SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Curtis who wrote (779)5/17/1999 10:37:00 AM
From: William Whitehead Jr.  Read Replies (1) of 2344
 
I was afraid of this. From talking to a number of people over the last couple of weeks I realized that they were expecting some early proof of the success of Phase III from ASCO. The bridging study was not properly understood.

Can anyone confirm that one U.S. analyst (at M. Lynch?) has set a new target of $20 for the stock. Saw this posted Stockhouse yesterday.

Whitey,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News